Cargando…
The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma
Objective: This study aimed to evaluate the applicability of adenosine deaminase (ADA), α-l-fucosidase (AFU), lactic acid (LAC), and their combined detection in the early diagnosis of chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Methods: A retrospective analys...
Autores principales: | Zhang, Wei, Chen, Zhong, Xue, Chengjun, Zhang, Yao, Wu, Lipei, Zhu, Jichao, Xuan, Shihai, Tian, Jiale, Pang, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453082/ https://www.ncbi.nlm.nih.gov/pubmed/34557505 http://dx.doi.org/10.3389/fmed.2021.740029 |
Ejemplares similares
-
Invited commentary on GETUG-AFU 16
por: Lee, W. Robert
Publicado: (2016) -
Serum AFU, 5’-NT and AFP as Biomarkers for Primary Hepatocellular Carcinoma Diagnosis
por: Junna, Zhu, et al.
Publicado: (2017) -
Case report: Hepatic tuberculosis mimicking hepatocellular carcinoma in a patient with cirrhosis induced by hepatitis B virus
por: Hu, Na, et al.
Publicado: (2022) -
Creating an AFU Learning Community Group to Combat Ageism
por: Andreoletti, Carrie, et al.
Publicado: (2020) -
EVIDENCE-BASED INTERGENERATIONAL PRACTICES SUPPORT AFU PRINCIPLES
por: Jarrott, Shannon, et al.
Publicado: (2022)